TYK2 INHIBITOR FORMULATIONS AND METHODS OF MAKING THE SAME
Pharmaceutical compositions and unit dosage forms can include a TYK2 inhibitor, methods of making the same. Methods of treatment can include administering the same to a patient. L'invention concerne des compositions pharmaceutiques et des formes galéniques unitaires pouvant comprendre un inhibi...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | FRY, David Shank WALD, Randy BETHUNE, Sarah Jean COLLIS, Alan John PHIMISTER, Andrew SMITHEY, Dan FENNEWALD, James MINCHOM, Colin SCHLESINGER, Erica LEVY, Stuart |
| description | Pharmaceutical compositions and unit dosage forms can include a TYK2 inhibitor, methods of making the same. Methods of treatment can include administering the same to a patient.
L'invention concerne des compositions pharmaceutiques et des formes galéniques unitaires pouvant comprendre un inhibiteur de TYK2, ainsi que leurs procédés de fabrication. L'invention concerne en outre des méthodes de traitement pouvant comprendre l'administration de ces compositions pharmaceutiques et formes galéniques unitaires à un patient. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023183900A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023183900A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023183900A13</originalsourceid><addsrcrecordid>eNrjZLAKifQ2UvD08_B08gzxD1Jw8w_yDfVxDPH09wtWcPRzUfB1DfHwdwlW8HdT8HX09vRzVwjxcFUIdvR15WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGxoYWxpYGBo6GxsSpAgBIbim4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TYK2 INHIBITOR FORMULATIONS AND METHODS OF MAKING THE SAME</title><source>esp@cenet</source><creator>FRY, David Shank ; WALD, Randy ; BETHUNE, Sarah Jean ; COLLIS, Alan John ; PHIMISTER, Andrew ; SMITHEY, Dan ; FENNEWALD, James ; MINCHOM, Colin ; SCHLESINGER, Erica ; LEVY, Stuart</creator><creatorcontrib>FRY, David Shank ; WALD, Randy ; BETHUNE, Sarah Jean ; COLLIS, Alan John ; PHIMISTER, Andrew ; SMITHEY, Dan ; FENNEWALD, James ; MINCHOM, Colin ; SCHLESINGER, Erica ; LEVY, Stuart</creatorcontrib><description>Pharmaceutical compositions and unit dosage forms can include a TYK2 inhibitor, methods of making the same. Methods of treatment can include administering the same to a patient.
L'invention concerne des compositions pharmaceutiques et des formes galéniques unitaires pouvant comprendre un inhibiteur de TYK2, ainsi que leurs procédés de fabrication. L'invention concerne en outre des méthodes de traitement pouvant comprendre l'administration de ces compositions pharmaceutiques et formes galéniques unitaires à un patient.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230928&DB=EPODOC&CC=WO&NR=2023183900A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230928&DB=EPODOC&CC=WO&NR=2023183900A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FRY, David Shank</creatorcontrib><creatorcontrib>WALD, Randy</creatorcontrib><creatorcontrib>BETHUNE, Sarah Jean</creatorcontrib><creatorcontrib>COLLIS, Alan John</creatorcontrib><creatorcontrib>PHIMISTER, Andrew</creatorcontrib><creatorcontrib>SMITHEY, Dan</creatorcontrib><creatorcontrib>FENNEWALD, James</creatorcontrib><creatorcontrib>MINCHOM, Colin</creatorcontrib><creatorcontrib>SCHLESINGER, Erica</creatorcontrib><creatorcontrib>LEVY, Stuart</creatorcontrib><title>TYK2 INHIBITOR FORMULATIONS AND METHODS OF MAKING THE SAME</title><description>Pharmaceutical compositions and unit dosage forms can include a TYK2 inhibitor, methods of making the same. Methods of treatment can include administering the same to a patient.
L'invention concerne des compositions pharmaceutiques et des formes galéniques unitaires pouvant comprendre un inhibiteur de TYK2, ainsi que leurs procédés de fabrication. L'invention concerne en outre des méthodes de traitement pouvant comprendre l'administration de ces compositions pharmaceutiques et formes galéniques unitaires à un patient.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAKifQ2UvD08_B08gzxD1Jw8w_yDfVxDPH09wtWcPRzUfB1DfHwdwlW8HdT8HX09vRzVwjxcFUIdvR15WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGxoYWxpYGBo6GxsSpAgBIbim4</recordid><startdate>20230928</startdate><enddate>20230928</enddate><creator>FRY, David Shank</creator><creator>WALD, Randy</creator><creator>BETHUNE, Sarah Jean</creator><creator>COLLIS, Alan John</creator><creator>PHIMISTER, Andrew</creator><creator>SMITHEY, Dan</creator><creator>FENNEWALD, James</creator><creator>MINCHOM, Colin</creator><creator>SCHLESINGER, Erica</creator><creator>LEVY, Stuart</creator><scope>EVB</scope></search><sort><creationdate>20230928</creationdate><title>TYK2 INHIBITOR FORMULATIONS AND METHODS OF MAKING THE SAME</title><author>FRY, David Shank ; WALD, Randy ; BETHUNE, Sarah Jean ; COLLIS, Alan John ; PHIMISTER, Andrew ; SMITHEY, Dan ; FENNEWALD, James ; MINCHOM, Colin ; SCHLESINGER, Erica ; LEVY, Stuart</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023183900A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>FRY, David Shank</creatorcontrib><creatorcontrib>WALD, Randy</creatorcontrib><creatorcontrib>BETHUNE, Sarah Jean</creatorcontrib><creatorcontrib>COLLIS, Alan John</creatorcontrib><creatorcontrib>PHIMISTER, Andrew</creatorcontrib><creatorcontrib>SMITHEY, Dan</creatorcontrib><creatorcontrib>FENNEWALD, James</creatorcontrib><creatorcontrib>MINCHOM, Colin</creatorcontrib><creatorcontrib>SCHLESINGER, Erica</creatorcontrib><creatorcontrib>LEVY, Stuart</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FRY, David Shank</au><au>WALD, Randy</au><au>BETHUNE, Sarah Jean</au><au>COLLIS, Alan John</au><au>PHIMISTER, Andrew</au><au>SMITHEY, Dan</au><au>FENNEWALD, James</au><au>MINCHOM, Colin</au><au>SCHLESINGER, Erica</au><au>LEVY, Stuart</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TYK2 INHIBITOR FORMULATIONS AND METHODS OF MAKING THE SAME</title><date>2023-09-28</date><risdate>2023</risdate><abstract>Pharmaceutical compositions and unit dosage forms can include a TYK2 inhibitor, methods of making the same. Methods of treatment can include administering the same to a patient.
L'invention concerne des compositions pharmaceutiques et des formes galéniques unitaires pouvant comprendre un inhibiteur de TYK2, ainsi que leurs procédés de fabrication. L'invention concerne en outre des méthodes de traitement pouvant comprendre l'administration de ces compositions pharmaceutiques et formes galéniques unitaires à un patient.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2023183900A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | TYK2 INHIBITOR FORMULATIONS AND METHODS OF MAKING THE SAME |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T19%3A06%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FRY,%20David%20Shank&rft.date=2023-09-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023183900A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |